Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
暂无分享,去创建一个
[1] G. Psomas. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties. , 2008, Journal of inorganic biochemistry.
[2] E. Efthimiadou,et al. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA , 2008 .
[3] E. Efthimiadou,et al. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure-activity relationship. , 2008, Journal of inorganic biochemistry.
[4] C. Dendrinou-Samara,et al. Synthesis, structure and interactions with DNA of novel tetranuclear, [Mn4(II/II/II/IV)] mixed valence complexes. , 2008, Journal of inorganic biochemistry.
[5] B. Fraisse,et al. Crystal structures and physico-chemical properties of Zn(II) and Co(II) tetraaqua(3-nitro-4-hydroxybenzoato) complexes: Their anticonvulsant activities as well as related (5-nitrosalicylato)–metal complexes , 2008 .
[6] E. Efthimiadou,et al. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin , 2008 .
[7] E. Efthimiadou,et al. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: synthesis, structure, antibacterial activity and interaction with DNA , 2008 .
[8] D. Vourloumis,et al. Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities. , 2008, Journal of medicinal chemistry.
[9] Y. Gong,et al. Synthesis, Characterization and Activity against Staphylococcus of Metal(II)‐Gatifloxacin Complexes , 2007 .
[10] M. Flores‐Álamo,et al. A copper(II) complex of 1,10‐phenanthroline and enrofloxacin , 2007 .
[11] J. Barton,et al. Metallo-intercalators and metallo-insertors. , 2007, Chemical communications.
[12] E. Efthimiadou,et al. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation , 2007 .
[13] G. Psomas,et al. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid , 2007 .
[14] F. Arjmand,et al. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells. , 2007, Inorganic chemistry.
[15] E. Efthimiadou,et al. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex. , 2007, Bioorganic & medicinal chemistry letters.
[16] A. Terzis,et al. Interaction of Fe(III) with herbicide-carboxylato ligands. Di-, tri- and tetra-nuclear compounds. Structure antimicrobial study and DNA interaction. , 2007 .
[17] A. Scorilas,et al. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine. , 2007, Journal of inorganic biochemistry.
[18] C. Raptopoulou,et al. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid. , 2006, Journal of inorganic biochemistry.
[19] Yingmei Liu,et al. DNA Binding and cleavage activity of Ni(II) complex with all-trans retinoic acid. , 2006, Journal of inorganic biochemistry.
[20] C. Raptopoulou,et al. Neutral and cationic mononuclear copper(II) complexes with enrofloxacin: structure and biological activity. , 2006, Journal of inorganic biochemistry.
[21] Z. Trávníček,et al. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity. , 2006, Journal of inorganic biochemistry.
[22] J. Ellena,et al. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine. , 2006, Journal of inorganic biochemistry.
[23] B. Nair,et al. Oxidative DNA cleavage mediated by a new copper (II) terpyridine complex: crystal structure and DNA binding studies. , 2005, Journal of inorganic biochemistry.
[24] Yang-guang Li,et al. Rationally designed, polymeric, extended metal-ciprofloxacin complexes. , 2005, Chemistry.
[25] S. Tabassum,et al. New modulated metallic macrocycles: Electrochemistry and their interaction with calf thymus DNA. , 2005, Acta biomaterialia.
[26] A. Terzis,et al. Inter-conversion of 15-MC-5 to 12-MC-4 manganese metallacrowns: structure and bioactivity of metallacrowns hosting carboxylato complexes. , 2005, Journal of inorganic biochemistry.
[27] S. García‐Granda,et al. Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin. , 2005, Journal of inorganic biochemistry.
[28] S. Dhar,et al. Effect of charge transfer bands on the photo-induced DNA cleavage activity of [1-(2-thiazolylazo)-2-naphtholato]copper(II) complexes. , 2005, Journal of inorganic biochemistry.
[29] L. Messori,et al. Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. , 2004, Inorganic chemistry.
[30] A. Powell,et al. A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline. , 2004, Bioorganic & medicinal chemistry letters.
[31] H. Hiasa,et al. Replacement of ParC α4 Helix with That of GyrA Increases the Stability and Cytotoxicity of Topoisomerase IV-Quinolone-DNA Ternary Complexes , 2004, Antimicrobial Agents and Chemotherapy.
[32] P. Sadler,et al. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. , 2003, Biochemistry.
[33] I. Turel,et al. Influence of copper(II) and magnesium(II) ions on the ciprofloxacin binding to DNA. , 2003, Journal of inorganic biochemistry.
[34] N. C. Kasuga,et al. Synthesis, structural characterization and antimicrobial activities of 12 zinc(II) complexes with four thiosemicarbazone and two semicarbazone ligands. , 2003, Journal of Inorganic Biochemistry.
[35] M. Takahata,et al. Inhibitory Activities of Quinolones against DNA Gyrase of Chlamydia pneumoniae , 2003, Antimicrobial Agents and Chemotherapy.
[36] I. Turel,et al. Interactions of oxovanadium(IV) and the quinolone family member--ciprofloxacin. , 2003, Journal of inorganic biochemistry.
[37] A. Gräslund,et al. 1H NMR studies of selective interactions of norfloxacin with double-stranded DNA. , 2003, Biochemical and biophysical research communications.
[38] P. Trikalitis,et al. High nuclearity nickel compounds with three, four or five metal atoms showing antibacterial activity. , 2003, Journal of inorganic biochemistry.
[39] C. Dendrinou-Samara,et al. The Effect of Fused 12-Membered Nickel Metallacrowns on DNA and their Antibacterial Activity , 2003, Bioinorganic chemistry and applications.
[40] I. Turel. The interactions of metal ions with quinolone antibacterial agents , 2002 .
[41] N. Farrell. Biomedical uses and applications of inorganic chemistry. An overview , 2002 .
[42] S. García‐Granda,et al. Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies. , 2002, Journal of inorganic biochemistry.
[43] C. F. Bittencourt,et al. LC determination of enrofloxacin. , 2002, Journal of Pharmaceutical and Biomedical Analysis.
[44] C. Dendrinou-Samara,et al. 15-MC-5 manganese metallacrowns hosting herbicide complexes. Structure and bioactivity. , 2002, Journal of inorganic biochemistry.
[45] Hiromu Sakurai,et al. Antidiabetic vanadium(IV) and zinc(II) complexes , 2002 .
[46] S. Pinelli,et al. New methyl pyruvate thiosemicarbazones and their copper and zinc complexes: synthesis, characterization, X-ray structures and biological activity. , 2001, Journal of inorganic biochemistry.
[47] X. You,et al. 2D molecular square grid with strong blue fluorescent emission: a complex of norfloxacin with zinc(II). , 2001, Inorganic Chemistry.
[48] Qianling Zhang,et al. DNA-binding and photocleavage studies of cobalt(III) polypyridyl complexes:. , 2001, Journal of inorganic biochemistry.
[49] P. A. Lay,et al. Syntheses and characterization of anti-inflammatory dinuclear and mononuclear zinc indomethacin complexes. Crystal structures of [Zn2(indomethacin)4(L)2] (L = N,N-dimethylacetamide, pyridine, 1-methyl-2-pyrrolidinone) and [Zn(indomethacin)2(L1)2] (L1 = ethanol, methanol). , 2000, Inorganic chemistry.
[50] C. Raptopoulou,et al. Structurally diverse copper(II)-carboxylato complexes: neutral and ionic mononuclear structures and a novel binuclear structure. , 2000, Inorganic chemistry.
[51] Roger Y. Tsien,et al. A New Cell-Permeable Fluorescent Probe for Zn2+ , 2000 .
[52] G. Bocelli,et al. Electron density distribution studies on ZnS4N2 chromophore in solution and solid phases: XPS and cyclic voltammetric studies on 1,10-phenanthroline and 2,2′-bipyridine adducts of bis(piperidinecarbodithioato-S,S′)zinc(II). Single crystal X-ray structure of (2,2′-bipyridine)bis-(piperidinecarbodithi , 1999 .
[53] D. Kyriakidis,et al. Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions. , 1998, Journal of inorganic biochemistry.
[54] B. Nordén,et al. BINDING MODE OF NORFLOXACIN TO CALF THYMUS DNA , 1998 .
[55] C. Raptopoulou,et al. CuII-herbicide complexes: structure and bioactivity , 1998 .
[56] S. Kuo,et al. Synthesis and Biological Evaluation of 6 , 7 , 2 ′ , 3 ′ , 4 ′-Substituted-1 , 2 , 3 , 4-tetrahydro-2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents , 1998 .
[57] B. Meunier,et al. DNA And RNA Cleavage by Metal Complexes , 1998 .
[58] S. Mitra,et al. Synthesis, characterization and structural studies of mono- and polynuclear complexes of zinc(II) with 1,10-phenanthroline, 2,2′-bipyridine and 4,4′-bipyridine , 1997 .
[59] C. Raptopoulou,et al. A TWO-DIMENSIONAL MANGANESE(II) CARBOXYLATO POLYMER. STRUCTURE, MAGNETISM,AND EPR STUDY , 1996 .
[60] K. Gruber,et al. Synthesis, crystal structure, and characterization of three novel compounds of the quinolone family member (norfloxacin) , 1996 .
[61] A. Terzis,et al. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes , 1996 .
[62] L. Hurley,et al. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. , 1995, Journal of medicinal chemistry.
[63] Xiao‐Ming Chen,et al. Preparation and crystal structures of bis(o-phenanthroline)(acetato)zinc(II) perchlorate and bis(2,2'-bipyridine)(pyridinioacetato)zinc(II) diperchlorate , 1994 .
[64] A. Castiñeiras,et al. Ni(II) and Zn(II) complexes with cinoxacin. Synthesis and characterization of M(Cx)2(DMSO)n(H2O)m (n=0, 2; m=2,4). Crystal structures of [M(Cx)2(DMSO)2].4H2O (M=Ni(II), Zn(II)) , 1993 .
[65] W D Wilson,et al. The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength. , 1993, Biochemistry.
[66] J. Pemán,et al. In vitro activity of sparfloxacin compared with those of five other quinolones , 1992, Antimicrobial Agents and Chemotherapy.
[67] E. Gibbs,et al. Long-range fluorescence quenching of ethidium ion by cationic porphyrins in the presence of DNA , 1991 .
[68] J. Barton,et al. On demonstrating DNA intercalation , 1990 .
[69] B. Baguley,et al. Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect. , 1984, Biochemistry.
[70] J. Villafranca,et al. Interactions of porphyrins with nucleic acids. , 1983, Biochemistry.
[71] B. Hathaway,et al. The structures of bis(2,2'-bipyridyl)mononitritocopper(II) tetrafluoroborate and bis(2,2'-bipyridyl)mononitritozinc(II) nitrate , 1981 .
[72] T. Krugh,et al. A comparative study of ethidium bromide complexes with dinucleotides and DNA: direct evidence for intercalation and nucleic acid sequence preferences. , 1978, Biochemistry.
[73] K. Nakamoto. Infrared and Raman Spectra of Inorganic and Coordination Compounds , 1978 .
[74] J. Olmsted,et al. Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids. , 1977, Biochemistry.
[75] M. Harding,et al. The structure of bis‐(N,N‐dimethyldithiocarbamato)pyridinezinc , 1967 .
[76] J. Marmur. A procedure for the isolation of deoxyribonucleic acid from micro-organisms , 1961 .
[77] S. Rice,et al. A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid , 1954 .